6,553
Views
36
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial

, , , , , , & show all
Pages 1051-1058 | Received 08 Sep 2016, Accepted 23 Nov 2016, Published online: 21 Feb 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.